FDA’s accelerated approval of cancer drugs is hasty and doubtful, says new report
HQ Team April 10, 2024: A new study has found that cancer drugs that got accelerated approval under the US Federal Drug Approval.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team April 10, 2024: A new study has found that cancer drugs that got accelerated approval under the US Federal Drug Approval.